Briol, Tertulo M.
HRN: 22-75-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2023
MUPIROCIN 2%, 15G (TUBE)
03/16/2023
03/23/2023
TOPICAL
15g
Bid
Malignant Otitis Media Vs RHS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes